UFP Technologies, Inc. (UFPT)
USD 193.62
(-8.15%)
USD 193.62
(-8.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 57.66 Million USD | 183.41% |
| 2022 | 21.64 Million USD | 2.0% |
| 2021 | 21.21 Million USD | 147.96% |
| 2020 | 8.55 Million USD | -48.25% |
| 2019 | 16.53 Million USD | -15.68% |
| 2018 | 19.61 Million USD | 67.72% |
| 2017 | 11.69 Million USD | -4.45% |
| 2016 | 12.23 Million USD | 4.46% |
| 2015 | 11.71 Million USD | 1.32% |
| 2014 | 11.56 Million USD | -33.55% |
| 2013 | 17.39 Million USD | 4.39% |
| 2012 | 16.66 Million USD | 6.04% |
| 2011 | 15.71 Million USD | 9.29% |
| 2010 | 14.38 Million USD | 75.8% |
| 2009 | 8.18 Million USD | -2.9% |
| 2008 | 8.42 Million USD | 16.25% |
| 2007 | 7.24 Million USD | 43.39% |
| 2006 | 5.05 Million USD | 132.83% |
| 2005 | 2.17 Million USD | 1.23% |
| 2004 | 2.14 Million USD | 242.16% |
| 2003 | -1.5 Million USD | -423.7% |
| 2002 | 465.99 Thousand USD | 112.46% |
| 2001 | -3.74 Million USD | -210.51% |
| 2000 | 3.38 Million USD | 2.58% |
| 1999 | 3.3 Million USD | 3.13% |
| 1998 | 3.2 Million USD | 6.67% |
| 1997 | 3 Million USD | 36.36% |
| 1996 | 2.2 Million USD | 100.0% |
| 1995 | 1.1 Million USD | 184.62% |
| 1994 | -1.3 Million USD | -244.44% |
| 1993 | 900 Thousand USD | -18.18% |
| 1992 | 1.1 Million USD | -15.38% |
| 1991 | 1.3 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 25.73 Million USD | 29.44% |
| 2024 Q2 | 19.13 Million USD | 18.3% |
| 2024 Q1 | 16.17 Million USD | 24.29% |
| 2023 Q2 | 17.04 Million USD | 32.72% |
| 2023 Q1 | 12.84 Million USD | 18.07% |
| 2023 FY | 61.33 Million USD | 183.41% |
| 2023 Q3 | 15.04 Million USD | -11.72% |
| 2023 Q4 | 13.01 Million USD | -13.52% |
| 2022 FY | 21.64 Million USD | 2.0% |
| 2022 Q4 | 10.87 Million USD | -1.14% |
| 2022 Q3 | 11 Million USD | -9.82% |
| 2022 Q2 | 12.19 Million USD | 193.32% |
| 2022 Q1 | 4.15 Million USD | -10.25% |
| 2021 Q1 | 5.3 Million USD | 7.35% |
| 2021 Q4 | 4.63 Million USD | -8.73% |
| 2021 FY | 21.21 Million USD | 147.96% |
| 2021 Q3 | 5.07 Million USD | -18.21% |
| 2021 Q2 | 6.2 Million USD | 17.11% |
| 2020 FY | 8.55 Million USD | -48.25% |
| 2020 Q1 | 5.07 Million USD | -24.77% |
| 2020 Q2 | 2.99 Million USD | -41.0% |
| 2020 Q3 | 3.72 Million USD | 24.42% |
| 2020 Q4 | 4.93 Million USD | 32.54% |
| 2019 Q1 | 5.25 Million USD | -4.39% |
| 2019 Q2 | 6.57 Million USD | 25.11% |
| 2019 Q3 | 6.13 Million USD | -6.6% |
| 2019 Q4 | 6.74 Million USD | 9.91% |
| 2019 FY | 16.53 Million USD | -15.68% |
| 2018 Q4 | 5.49 Million USD | -6.64% |
| 2018 FY | 19.61 Million USD | 67.72% |
| 2018 Q3 | 5.88 Million USD | 3.81% |
| 2018 Q1 | 2.56 Million USD | 24.59% |
| 2018 Q2 | 5.66 Million USD | 121.1% |
| 2017 Q4 | 2.05 Million USD | -17.68% |
| 2017 FY | 11.69 Million USD | -4.45% |
| 2017 Q2 | 3.93 Million USD | 22.62% |
| 2017 Q1 | 3.2 Million USD | 41.94% |
| 2017 Q3 | 2.5 Million USD | -36.39% |
| 2016 Q1 | 1.7 Million USD | -34.56% |
| 2016 FY | 12.23 Million USD | 4.46% |
| 2016 Q3 | 4.08 Million USD | -2.67% |
| 2016 Q4 | 2.25 Million USD | -44.67% |
| 2016 Q2 | 4.19 Million USD | 146.07% |
| 2015 Q4 | 2.6 Million USD | -14.76% |
| 2015 FY | 11.71 Million USD | 1.32% |
| 2015 Q2 | 3.48 Million USD | 35.84% |
| 2015 Q1 | 2.56 Million USD | 3.42% |
| 2015 Q3 | 3.05 Million USD | -12.39% |
| 2014 Q4 | 2.48 Million USD | -19.88% |
| 2014 Q3 | 3.09 Million USD | 11.12% |
| 2014 Q2 | 2.78 Million USD | -12.74% |
| 2014 Q1 | 3.19 Million USD | -40.0% |
| 2014 FY | 11.56 Million USD | -33.55% |
| 2013 Q2 | 4.63 Million USD | 56.73% |
| 2013 FY | 17.39 Million USD | 4.39% |
| 2013 Q1 | 2.95 Million USD | -35.77% |
| 2013 Q3 | 4.48 Million USD | -3.22% |
| 2013 Q4 | 5.32 Million USD | 18.76% |
| 2012 Q1 | 3.68 Million USD | -12.63% |
| 2012 Q3 | 4.07 Million USD | -5.48% |
| 2012 Q4 | 4.6 Million USD | 13.07% |
| 2012 Q2 | 4.3 Million USD | 16.75% |
| 2012 FY | 16.66 Million USD | 6.04% |
| 2011 FY | 15.71 Million USD | 9.29% |
| 2011 Q4 | 4.22 Million USD | 29.31% |
| 2011 Q3 | 3.26 Million USD | -24.38% |
| 2011 Q2 | 4.31 Million USD | 10.41% |
| 2011 Q1 | 3.9 Million USD | -12.58% |
| 2010 FY | 14.38 Million USD | 75.8% |
| 2010 Q1 | 2.44 Million USD | -43.0% |
| 2010 Q2 | 3.65 Million USD | 49.67% |
| 2010 Q3 | 3.8 Million USD | 3.93% |
| 2010 Q4 | 4.47 Million USD | 17.59% |
| 2009 FY | 8.18 Million USD | -2.9% |
| 2009 Q2 | 955.13 Thousand USD | 51.04% |
| 2009 Q1 | 632.38 Thousand USD | -63.78% |
| 2009 Q4 | 4.28 Million USD | 79.97% |
| 2009 Q3 | 2.38 Million USD | 149.56% |
| 2008 FY | 8.42 Million USD | 16.25% |
| 2008 Q2 | 2.64 Million USD | 34.46% |
| 2008 Q1 | 1.96 Million USD | -34.11% |
| 2008 Q4 | 1.74 Million USD | -15.62% |
| 2008 Q3 | 2.06 Million USD | -21.73% |
| 2007 Q4 | 2.98 Million USD | 92.55% |
| 2007 FY | 7.24 Million USD | 43.39% |
| 2007 Q3 | 1.54 Million USD | -10.29% |
| 2007 Q2 | 1.72 Million USD | 75.05% |
| 2007 Q1 | 986.7 Thousand USD | -35.59% |
| 2006 FY | 5.05 Million USD | 132.83% |
| 2006 Q4 | 1.53 Million USD | 73.38% |
| 2006 Q3 | 883.49 Thousand USD | -37.66% |
| 2006 Q2 | 1.41 Million USD | 16.01% |
| 2006 Q1 | 1.22 Million USD | 47.94% |
| 2005 Q3 | 18.65 Thousand USD | -97.52% |
| 2005 Q4 | 825.74 Thousand USD | 4326.85% |
| 2005 Q2 | 753.43 Thousand USD | 31.5% |
| 2005 Q1 | 572.95 Thousand USD | -31.23% |
| 2005 FY | 2.17 Million USD | 1.23% |
| 2004 Q4 | 833.11 Thousand USD | 64.06% |
| 2004 FY | 2.14 Million USD | 242.16% |
| 2004 Q2 | 542.77 Thousand USD | 108.19% |
| 2004 Q1 | 260.71 Thousand USD | 118.26% |
| 2004 Q3 | 507.8 Thousand USD | -6.44% |
| 2003 Q1 | -425.93 Thousand USD | -327.54% |
| 2003 FY | -1.5 Million USD | -423.7% |
| 2003 Q4 | -1.42 Million USD | -679.38% |
| 2003 Q3 | 246.38 Thousand USD | 149.81% |
| 2003 Q2 | 98.63 Thousand USD | 123.16% |
| 2002 Q1 | -281.75 Thousand USD | 82.67% |
| 2002 Q4 | 187.18 Thousand USD | -8.53% |
| 2002 FY | 465.99 Thousand USD | 112.46% |
| 2002 Q3 | 204.63 Thousand USD | -42.51% |
| 2002 Q2 | 355.92 Thousand USD | 226.32% |
| 2001 Q3 | -1.49 Million USD | -589.31% |
| 2001 FY | -3.74 Million USD | -210.51% |
| 2001 Q1 | -407.02 Thousand USD | -137.6% |
| 2001 Q2 | -216.34 Thousand USD | 46.85% |
| 2001 Q4 | -1.62 Million USD | -9.05% |
| 2000 Q4 | 1.08 Million USD | 47.8% |
| 2000 Q3 | 732.46 Thousand USD | -16.55% |
| 2000 Q2 | 877.75 Thousand USD | 27.25% |
| 2000 Q1 | 689.76 Thousand USD | -31.02% |
| 2000 FY | 3.38 Million USD | 2.58% |
| 1999 Q3 | 600 Thousand USD | -33.33% |
| 1999 Q2 | 900 Thousand USD | 28.57% |
| 1999 Q1 | 700 Thousand USD | -36.36% |
| 1999 FY | 3.3 Million USD | 3.13% |
| 1999 Q4 | 1 Million USD | 66.67% |
| 1998 Q1 | 500 Thousand USD | -54.55% |
| 1998 Q2 | 700 Thousand USD | 40.0% |
| 1998 Q3 | 1 Million USD | 42.86% |
| 1998 Q4 | 1.1 Million USD | 10.0% |
| 1998 FY | 3.2 Million USD | 6.67% |
| 1997 FY | 3 Million USD | 36.36% |
| 1997 Q2 | 600 Thousand USD | 20.0% |
| 1997 Q3 | 700 Thousand USD | 16.67% |
| 1997 Q1 | 500 Thousand USD | -28.57% |
| 1997 Q4 | 1.1 Million USD | 57.14% |
| 1996 Q2 | 500 Thousand USD | 25.0% |
| 1996 FY | 2.2 Million USD | 100.0% |
| 1996 Q3 | 600 Thousand USD | 20.0% |
| 1996 Q4 | 700 Thousand USD | 16.67% |
| 1996 Q1 | 400 Thousand USD | 0.0% |
| 1995 Q3 | 300 Thousand USD | 50.0% |
| 1995 Q4 | 400 Thousand USD | 33.33% |
| 1995 Q1 | 100 Thousand USD | 133.33% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 FY | 1.1 Million USD | 184.62% |
| 1994 Q3 | -200 Thousand USD | 33.33% |
| 1994 Q1 | -400 Thousand USD | 98.16% |
| 1994 Q2 | -300 Thousand USD | 25.0% |
| 1994 FY | -1.3 Million USD | -244.44% |
| 1994 Q4 | -300 Thousand USD | -50.0% |
| 1993 Q1 | 7.5 Million USD | 136.06% |
| 1993 Q2 | 7.5 Million USD | 0.0% |
| 1993 Q3 | 7.6 Million USD | 1.33% |
| 1993 Q4 | -21.7 Million USD | -385.53% |
| 1993 FY | 900 Thousand USD | -18.18% |
| 1992 Q3 | 7.3 Million USD | 0.0% |
| 1992 FY | 1.1 Million USD | -15.38% |
| 1992 Q4 | -20.8 Million USD | -384.93% |
| 1992 Q1 | 7.3 Million USD | 137.06% |
| 1992 Q2 | 7.3 Million USD | 0.0% |
| 1991 Q4 | -19.7 Million USD | -381.43% |
| 1991 FY | 1.3 Million USD | 0.0% |
| 1991 Q1 | 7 Million USD | 0.0% |
| 1991 Q2 | 7 Million USD | 0.0% |
| 1991 Q3 | 7 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 501.532% |
| Cerus Corporation | -30.05 Million USD | 291.874% |
| OrthoPediatrics Corp. | -25.76 Million USD | 323.799% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 642.907% |
| Talis Biomedical Corporation | -66.81 Million USD | 186.304% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 433.395% |
| Inogen, Inc. | -109.38 Million USD | 152.716% |
| Spectral AI, Inc. | -12.98 Million USD | 544.116% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 192.131% |
| CVRx, Inc. | -43.1 Million USD | 233.782% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 1734.467% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 563.985% |
| Orthofix Medical Inc. | -139.11 Million USD | 141.452% |
| Venus Concept Inc. | -28.3 Million USD | 303.695% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 206.73% |
| Bioventus Inc. | -81.72 Million USD | 170.559% |
| BrainsWay Ltd. | -4.92 Million USD | 1270.367% |
| Envoy Medical, Inc. | -18.37 Million USD | 413.886% |
| electroCore, Inc. | -18.8 Million USD | 406.642% |
| IceCure Medical Ltd | -15.57 Million USD | 470.211% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 218.939% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 433.935% |
| MaxCyte, Inc. | -48.29 Million USD | 219.39% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 582.332% |
| Nexalin Technology, Inc. | -5.69 Million USD | 1112.307% |
| PAVmed Inc | -68.79 Million USD | 183.82% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 201.947% |
| RxSight, Inc. | -50.08 Million USD | 215.132% |
| Sight Sciences, Inc. | -57.27 Million USD | 200.681% |
| SI-BONE, Inc. | -46.93 Million USD | 222.87% |
| TELA Bio, Inc. | -44.07 Million USD | 230.832% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 206.489% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 212.126% |
| LivaNova PLC | -68.49 Million USD | 184.183% |
| 908 Devices Inc. | -42.75 Million USD | 234.861% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 133.256% |
| Nemaura Medical Inc. | -9.59 Million USD | 700.965% |
| NeuroPace, Inc. | -27.17 Million USD | 312.203% |
| LENSAR, Inc. | -12.22 Million USD | 571.535% |
| Apyx Medical Corporation | -17.25 Million USD | 434.11% |
| Cutera, Inc. | -156.23 Million USD | 136.91% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 770.2% |
| BioSig Technologies, Inc. | -28.51 Million USD | 302.245% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 165.797% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 356.901% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 48.295% |
| Axonics, Inc. | -26.05 Million USD | 321.299% |
| Outset Medical, Inc. | -169.77 Million USD | 133.966% |
| IRIDEX Corporation | -10 Million USD | 676.237% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 152.82% |
| IRadimed Corporation | 20.03 Million USD | -187.81% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 799.382% |
| INVO Bioscience, Inc. | -6.76 Million USD | 952.116% |
| Telesis Bio, Inc. | -35.15 Million USD | 264.051% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -302.401% |
| Varex Imaging Corporation | 32.1 Million USD | -79.639% |
| Quipt Home Medical Corp. | 3.91 Million USD | -1371.396% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 575.266% |
| Pulmonx Corporation | -61.93 Million USD | 193.104% |
| Dynatronics Corporation | -2.27 Million USD | 2636.858% |
| Modular Medical, Inc. | -17.52 Million USD | 428.963% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 493.907% |
| Semler Scientific, Inc. | 22.25 Million USD | -159.094% |
| InMode Ltd. | 195.66 Million USD | 70.528% |
| Bruker Corporation | 436.9 Million USD | 86.802% |
| Cytosorbents Corporation | -31.2 Million USD | 284.766% |
| DexCom, Inc. | 597.7 Million USD | 90.352% |
| Align Technology, Inc. | 643.33 Million USD | 91.037% |
| Viveve Medical, Inc. | -21.55 Million USD | 367.545% |
| ZimVie Inc. | -30.93 Million USD | 286.38% |
| Movano Inc. | -29.69 Million USD | 294.22% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 307.089% |
| Nexalin Technology, Inc. | -5.69 Million USD | 1112.307% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 1734.467% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 124.724% |
| Profound Medical Corp. | -28.61 Million USD | 301.51% |
| Insulet Corporation | 220 Million USD | 73.789% |
| enVVeno Medical Corporation | -25.23 Million USD | 328.481% |
| Surmodics, Inc. | -5.64 Million USD | 1121.506% |
| iCAD, Inc. | -7.68 Million USD | 849.954% |
| Nuwellis, Inc. | -17.63 Million USD | 427.079% |
| Biotricity, Inc. | -8.82 Million USD | 753.174% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 146.072% |
| Aethlon Medical, Inc. | -12.63 Million USD | 556.326% |
| InspireMD, Inc. | -21.14 Million USD | 372.733% |
| PAVmed Inc. | -68.79 Million USD | 183.82% |
| BIOLASE, Inc. | -17.93 Million USD | 421.481% |
| Beyond Air, Inc. | -63 Million USD | 191.521% |
| FONAR Corporation | 16.53 Million USD | -248.731% |
| AxoGen, Inc. | -21.46 Million USD | 368.68% |
| Vivani Medical, Inc. | -26.96 Million USD | 313.848% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -219.628% |
| Inari Medical, Inc. | -14.03 Million USD | 510.946% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 1270.225% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 1014.464% |
| Tenon Medical, Inc. | -15.72 Million USD | 466.656% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 871.528% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 235.025% |
| AdaptHealth Corp. | -598.4 Million USD | 109.636% |
| Sintx Technologies, Inc. | -13.35 Million USD | 531.681% |
| NanoVibronix, Inc. | -3.43 Million USD | 1778.231% |
| Quanterix Corporation | -49.7 Million USD | 216.022% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 575.266% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 15195.288% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 117.241% |
| TransMedics Group, Inc. | -28.72 Million USD | 300.731% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 344.215% |
| NeuroMetrix, Inc. | -7.15 Million USD | 906.318% |
| Hyperfine, Inc. | -48.11 Million USD | 219.846% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 188.678% |
| Biomerica, Inc. | -6.36 Million USD | 1005.67% |
| Bone Biologics Corporation | -9.42 Million USD | 711.605% |
| AVITA Medical, Inc. | -40.4 Million USD | 242.725% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 659.236% |
| Silk Road Medical, Inc | -59.27 Million USD | 197.289% |